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Primary Care, KU Leuven Campus Kulak Kortrijk, Kortrijk, BelgiumIntroduction: Glomerular filtration rate (GFR) is measured from the late plasma disappearance curve of an
exogenous tracer, after correction for the early decay—corresponding to the distribution of the tracer—using
various equations. These equations display the highest discrepancies in the GFR range above 90 ml/min per
1.73 m2, and their respective performances against a reference, urinary GFR measurement are unclear.
Methods: In patients with mGFR >90 ml/min per 1.73 m2 from 6 different cohorts, we compared GFR
obtained from the plasma clearance of iohexol or 51Cr-ethylenediamine tetraacetic acid (EDTA), after
correction using Chantler (C), Bröchner-Mortensen (BM), Fleming (F), Jodal-Bröchner-Mortensen (JBM),
and Ng (N) equations, with urinary clearance of the same tracers or inulin.
Results: In 438 participants (median age 41 [39–42] years, 43% women), the median urinary clearance was
100.8 (94.7–112.6) ml/min per 1.73 m2. Plasma clearances using the correction equations were 105.7 (96.8–
119.2), 102.4 (95.2–112.9), 100.7 (93.6–111.1), 102.6 (95.2–113.4), and 106.0 (98.2–117.6) ml/min per 1.73 m2
for C, BM, F, JBM, and N, respectively. Concordance correlation coefficients between plasma and urinary
clearances were poor for all equations. Compared with urinary clearances, BM, F, and JBM displayed the
best accuracy within 10% (73%, 72%, and 71%, respectively, vs. 63% and 66% for C and N), whereas BM
and JBM had the lowest median biases. Accuracy of all equations was especially low in the hyperfiltration
range (urinary clearance >130 ml/min per 1.73 m2).
Conclusion: The BM and JBM equations displayed the best overall performances to correct for the early
disappearance curve. Results of these equations should be interpreted with caution, especially in the
highest GFR range.
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easuring glomerular filtration rate (GFR) remains
indicated in specific conditions.1,2 Plasma clear-
ance is routinely calculated from the plasma disap-
pearance of an exogenous marker obtained during the
renal excretion phase (the second or slow GFR
compartment).3,4 Different equations are used to correct
the slow compartment for the first or earlyKidney International Reports (2021) 6, 1622–1628
Table 1. Different equations to correct for the absence of the early
compartment
Reference
Markers Used for the
Development Equation
Chantler6 51Cr-EDTA GFR ¼ 0.87  C2
Bröchner-Mortensen7 51Cr-EDTA GFR ¼ 0.990778  C2 –
0.001218 C22
Fleming8 99mTc-DTPA GFR ¼ C2/(1 þ 0.0017  C2)
Jodal-Bröchner-
Mortensen9
51Cr-EDTA GFR ¼ C2/[1 þ (0.00185 
BSA–0.3)  C2]
Ng10 Iohexol GFR ¼ C2/(1 þ 0.0012  C2)
BSA, body surface area; GFR, glomerular filtration rate.
C2 is the GFR result of the second compartment calculated with the slope-intercept
method.
P Delanaye et al.: Plasma vs. Urinary Clearances in High GFR Ranges CLINICAL RESEARCHcompartment, which corresponds to the distribution of
the marker in the body. Recently, in a large cohort of
patients (n¼5459) covering the whole GFR range (from
3 to 200 ml/min per 1.73 m2), we showed that all these
equations (except the C equation) yielded very
concordant results, at least in a GFR range below 90 ml/
min per 1.73 m2.5 The goal of the present study was to
compare GFR results obtained with the plasma clear-
ances corrected by C,6 BM,7 F,8 JBM,9 and N10 equa-
tions (equations provided in Table 1) with urinary
clearance in subjects with GFR greater than 90 ml/min
per 1.73 m2, that is, in the range of GFR with the
highest discrepancies when these different equations
are used to correct plasma clearances.5
From 6 different cohorts, we collected results of
measured GFR by urinary clearances over 90 ml/min
per 1.73 m2 (inulin, iohexol, or 51Cr-EDTA) and
compared results with plasma clearance (iohexol or
51Cr-EDTA) corrected with the different correction
equations. Comparison of urinary and plasma clear-
ances concerned 51Cr-EDTA/51Cr-EDTA in 2 cohorts,
inulin/iohexol in 3 cohorts, and iohexol/iohexol in one.METHODS
We collected data on urinary clearances for 438 subjects,
all with a GFR result $90 ml/min per 1.73 m2. Six
different centers have collaborated on this project using
various markers for plasma and urinary clearances,
respectively: Paris (Bichat hospital), France (n ¼ 315;
51Cr-EDTA/51Cr-EDTA); Créteil, France (n¼ 62; iohexol/
iohexol); Lyon, France (n ¼ 35; iohexol/inulin); Malmö,
Sweden (n ¼ 15; iohexol/inulin); Paris (Pompidou hos-
pital), France (n ¼ 7; 51Cr-EDTA/51Cr-EDTA); and
Kingston, Canada (n¼ 4; iohexol/inulin). All centers are
experts in GFR measurement and the data used here are
from larger cohorts previously described.5,11–16
Retrospective use of anonymous data was approved by
the respective ethics committees.
All measurements were performed in the morning in
fasting (or after a light protein-free breakfast) andKidney International Reports (2021) 6, 1622–1628resting conditions. All subjects were adults ($18 years).
Plasma clearances were calculated from concentrations
obtained at 3 different time-points (12015, 18015 and
24015 minutes after injection). Only adequate fit re-
sults were retained for further analysis (i.e., R2 $ 0.975).
The “slow” GFR was calculated as the total dose of
iohexol or 51Cr-EDTA injected, divided by the area
under the curve (AUC) of the late concentration-time
curve, calculated from the 1-compartment slope-
intercept method. We then applied 5 different correc-
tion equations to compensate for the absence of the early
compartment: C6, BM7, F8, JBM9, and N10. Indexing GFR
before or after the correction for the early compartment
is debatable, even if the impact on the results is relevant
only in the extreme body mass index (BMI) range.17,18
Because body surface area indexation is considered in
some models,9 we decided to index all results before
applying the correction. Urinary clearances were per-
formed using local protocols with the following urine
collections: Paris-Bichat: six 30-minute clearance pe-
riods; Créteil: six 30-minute clearance periods; Lyon:
three to four 30-minute clearance periods; Malmö: two
60-minute clearance periods; Paris-Pompidou: six 30-
minute clearance periods; and Kingston: three 60-
minute clearance periods. All urinary clearances were
measured after a bolus injection of the reference marker,
except in Lyon, Kingston and Malmö where inulin was
continuously infused.11,13 The plasma clearance could be
calculated from the same unique procedure when the
same marker is considered (and injected in bolus). When
a different marker was used in urinary and plasma
clearances, both markers were injected at the same
moment during the same procedure (see details in
Dubourg et al.,11 Sterner et al., 13 and White et al.15).
Data are expressed as mean  standard deviation
(SD) when distribution was normal and as median with
interquartile range (IQR) when not. Normality was
assessed by the Shapiro-Wilk test. We calculated Lin’s
concordance correlation coefficient between plasma
clearance corrected for the different equations and
urinary clearance.19 Bias (systematic difference) was
calculated as the median difference between plasma
clearance corrected for the different equations and
urinary clearance. We considered plasma clearances as
unbiased when the bias was not different from zero
(when the 95% confidence interval included zero).
Imprecision (random error) was calculated as the IQR of
the bias. Results were also plotted using Bland and
Altman analysis (with bias as the mean difference be-
tween plasma clearance corrected for the different
equations and urinary clearances).20 We calculated ac-
curacies (as the percentage of relative difference)
within 20%, 10%, and 5% between urinary and
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Figure 1. Bland and Altman analyses between urinary clearances and plasma clearances with different correction equations: (a) C: Chantler,
(b) BM: Bröchner-Mortensen, (c) F: Fleming, (d) JBM: Jodal- Bröchner-Mortensen, (e) N: Ng. All results are in milliliters per minute per 1.73 m2.
SD, standard deviation.
CLINICAL RESEARCH P Delanaye et al.: Plasma vs. Urinary Clearances in High GFR RangesMcNemar test.21 Imprecision was compared between
equations according to the Pitman test for comparing
variances of correlated samples. Because we considered16245 equations, we proposed to use P < 0.05/6 ¼ 0.008 to
claim statistical significance according to Bonferroni
correction for multiple testing.Kidney International Reports (2021) 6, 1622–1628






Median Bias (95% CI)
(ml/min per 1.73 m2)
IQR of the Bias







C 0.6584 (0.6163–0.7182) 4.0 (2.4–5.1) 14.4 34 63 91
BM 0.6704 (0.6163–0.7182) 0.3 (–0.7 to 1.3) 12.0 43 73 93
F 0.6683 (0.6142–0.7162) –1.4 (–2.5 to –0.3) 11.9 44 72 94
JBM 0.6753 (0.6212–0.7229) 0.5 (–0.5 to 1.4) 12.3 43 71 92
N 0.6651 (0.6108–0.7133) 3.8 (2.9–4.9) 12.7 37 66 93
BM, Bröchner-Mortensen; C, Chantler; CCC, concordance correlation coefficient; CI, confidence interval; IQR, interquartile range; F, Fleming; JBM, Jodal-Bröchner-Mortensen; N, Ng.
P Delanaye et al.: Plasma vs. Urinary Clearances in High GFR Ranges CLINICAL RESEARCHRESULTS
Among the 438 participants, median age was 41 (32–49)
years and 42.9% were women. Mean height and me-
dian body weight were 1719 cm and 73.5 (64–83) kg,
respectively. Mean BMI and mean body surface area
were 25 (22–28) and 1.880.22 m2, respectively. Me-
dian mGFR measured by urinary clearance was 100.8
(94.7–112.6) ml/min per 1.73 m2. Median plasma
clearances with C, BM, F, JBM, and N corrections were
105.7 (96.8–119.2), 102.4 (95.2–112.9), 100.7 (93.6–
111.1), 102.6 (95.2–113.4), and 106.0 (98.2–117.6) ml/
min per 1.73 m2, respectively. Bland and Altman plots
are shown in Figure 1. Lin concordance correlation
coefficient, bias, and precision are reported in Table 2
in the whole population. Concordance correlation co-
efficients showed poor agreement between plasma
clearance and urinary clearance for all 5 equations.
Regarding bias, the BM and JBM equations showed no
bias with the urinary clearance, whereas F under-
estimated and C and N overestimated urinary clear-
ances. Imprecision (variance of the bias) was higher for
C compared with the other equations (P < 0.0001).
Imprecision was also higher for N compared with BM,
F, and JBM (P < 0.0001). Accuracy within 5% was
poorer for C compared with BM, F, JBM, and N (P ¼
0.0001, P ¼ 0.0003, P < 0.0001, and P ¼ 0.0351,
respectively), and for N compared to BM, F, and JBM
(P ¼ 0.0167, 0.0070, and 0.0164, respectively). Cor-
recting for multiple testing, only the difference be-
tween C-BM, C-F, C-JBM, and F-N remained significant.
All other accuracies within 5% were similar. Accuracy
within 10% was significantly lower for C compared
with BM, F, JBM, and N (P < 0.0001, P ¼ 0.0001, P <
0.0001, and P ¼ 0.0066, respectively), and for N
compared with BM, F, and JBM (P < 0.0001, P ¼
0.0049, and P ¼ 0.0065, respectively). All other accu-
racies within 10% were similar. Accuracy within 20%
was similar for all equations. Analyses according to
marker used and patient’s characteristics (subgroup of
GFR range, age, gender, and BMI) are shown in
Tables 3 and 4. The best accuracy between plasma and
urinary clearances was found when 51Cr-EDTA wasKidney International Reports (2021) 6, 1622–1628used in the plasma and urinary clearances. Precision
was also better when the same marker was considered
in both plasma and urinary clearances (iohexol/iohexol
and even more 51Cr-EDTA/51Cr-EDTA) (Table 3). Ac-
curacies observed in most subgroup analyses according
to GFR levels, gender, BMI, and age were globally
similar to accuracies observed in the whole population
(with the same conclusion: the performance of N and C
equations was slightly poorer). No difference of accu-
racy was observed between men and women (all P
values >0.008). Accuracies were poorer in subjects
with hyperfiltration (GFR > 130 ml/min per 1.73 m2)
and in low BMI (<20) (Table 4). In subjects with
hyperfiltration, there is a trend for a better accuracy
within 5% for the C equation compared with the BM
and F equations (P ¼ 0.0391 and 0.0215, respectively)
and for the N equation compared with BM and F
equations (P ¼ 0.0313 and 0.0156, respectively). In
subjects with low BMI, all equations had the same poor
performances.DISCUSSION
Concordance between the BM, F, JBM, and N equations
to correct the slow compartment is very high. Sub-
analyses, however, revealed that the concordance was
less impressive at high GFR levels.5,22 In the current
analysis using urinary clearances over 90 ml/min per
1.73 m2 as the reference, we showed that plasma clear-
ance corrected by the BM and JBM equations was un-
biased compared with urinary clearances, whereas the F
equation underestimated and the C and N equations
overestimated urinary clearances. Imprecision was
lowest for BM, F and JBM (and imprecision of C higher
than N). Also, accuracy was slightly poorer for the N
and C equations. Several elements of the study findings
warrant further discussion. Overall, the accuracy of
corrected plasma clearances compared with urinary
clearances was lower than the concordance we previ-
ously described between the corrected plasma clear-
ances.5 This is not unexpected. Imprecision in plasma
clearances might be due to the analytical imprecision of
the measurements of the marker (such an analytical1625
Table 3. Performance of plasma clearances with different equations correcting the slow GFR for the early compartment compared to urinary
clearances in subgroups according to reference markers
CCC
(95% CI)
Median Bias (95% CI)
(ml/min per 1.73 m2)
IQR







51Cr-EDTA/ 51Cr-EDTA (n ¼ 322)
C 0.6925 (0.6354–0.7421) 3.3 (1.9 to 5.0) 12.9 38 70 94
BM 0.7245 (0.6684–0.7724) 0.2 (–1.0 to 1.3) 10.3 48 80 96
F 0.7169 (0.6603–0.7655) –1.5 (–2.6 to –0.4) 10.3 50 78 97
JBM 0.7253 (0.6692–0.7732) –0.02 (–1.2 to 0.8) 10.6 48 78 96
N 0.7032 (0.6456–0.7529) 3.7 (2.6–4.9) 11.3 41 73 96
Iohexol/inulin (n ¼ 54)
C 0.6203 (0.4394–0.7529) –2.7 (–9.0 to 3.0) 19.0 33 52 81
BM 0.5724 (0.3917–0.7107) –7.3 (–14.0 to –3.1) 19.4 35 56 78
F 0.5536 (0.3724–0.6941) –8.9 (–15.4 to –4.8) 19.3 30 50 78
JBM 0.5728 (0.3873–0.7137) –7.2 (–14.2 to –2.5) 19.8 37 54 78
N 0.6286 (0.4435–0.7622) –3.5 (–10.9 to 1.6) 19.1 39 54 85
Iohexol/iohexol (n ¼ 62)
C 0.5946 (0.4444–0.7122) 13.6 (9.1–17.8) 17.6 13 35 79
BM 0.6207 (0.4633–0.7401) 8.7 (5.1–11.6) 11.3 24 53 90
F 0.6568 (0.5039–0.7698) 7.1 (3.7–10.0) 11.4 24 58 94
JBM 0.6448 (0.4917–0.7592) 9.0 (5.6–12.0) 11.8 23 52 87
N 0.5884 (0.4336–0.7095) 12.9 (9.6–16.1) 13.3 15 37 82
BM, Bröchner-Mortensen; C, Chantler; CCC, concordance correlation coefficient; CI, confidence interval; F, Fleming; IQR, interquartile range; JBM, Jodal-Bröchner-Mortensen; N, Ng.
CLINICAL RESEARCH P Delanaye et al.: Plasma vs. Urinary Clearances in High GFR Rangesimprecision being theoretically higher in high GFR
ranges where the concentrations of the marker are
particularly low at the last time point).23 These impre-
cisions are similar when plasma clearances with different
correction equations are compared between themselves
but are higher when compared to a totally different
methodology, like urinary clearances. When comparing
plasma to urinary clearance as the reference, errors in
the reference method should be considered as well,
notably because of imprecision of urine collections, even
in expert centers as those who participated in the currentTable 4. Accuracy (5%/10%) by equation according to different
subgroups defined by GFR levels, gender, BMI, and age
C BM F JBM N
GFR (ml/min per 1.73 m2)
90–130 (n¼406) 34/63 46/76 47/75 46/75 38/67
90–100 (n¼207) 37/67 47/79 51/80 48/77 39/68
100–110 (n¼103) 34/64 46/76 46/74 45/76 38/71
110–120 (n¼66) 32/61 44/76 41/74 44/73 39/67
120–130 (n¼30) 20/43 37/52 10/53 37/57 23/53
>130 (n¼32) 28/53 6/34 3/25 13/28 25/45
Gender
Men (n¼250) 37/66 45/75 44/73 46/73 41/68
Women (n¼188) 30/57 40/70 43/70 40/69 31/62
BMI (kg/m2)
#20 (n¼31) 19/42 23/55 26/48 29/55 19/52
20–30 (n¼346) 35/65 43/75 45/75 44/74 38/68
$30 (n¼61) 34/61 49/67 46/67 46/66 36/62
Age (yr)
<40 (n¼203) 31/57 36/68 39/68 37/67 33/58
$40 (n¼235) 37/68 48/77 48/75 49/75 40/73
BM, Bröchner-Mortensen; BMI, body mass index; C, Chantler; F, Fleming; GFR,
glomerular filtration rate; JBM, Jodal-Bröchner-Mortensen; N, Ng.
All results are expressed in %.
1626study. This being said, concordance between urinary
and plasma clearances in the present analysis is compa-
rable to that reported in previous similar studies with
smaller samples.11,22,24,25 The correcting equations have
been developed in populations with few data higher
than 90 ml/min per 1.73 m2. The lower accuracy of
correcting models in the high GFR range was suggested
by Fleming.26 However, in the current analysis, we do
not confirm an added value of neither the F nor JBM
equation compared with the BM equation to correct the
slow GFR compartment in high GFR ranges.9 Concor-
dance between plasma and urinary clearances might also
be poorer in patients with increased volume of distri-
bution (cirrhosis, edema, etc.) who were not excluded
from the analysis.27
Subanalysis according to the reference marker
used in plasma and urinary clearances was per-
formed. Imprecision of plasma clearances compared
to urinary clearances was lower when iohexol, and
even more when 51Cr-EDTA, were used both in
plasma and urinary protocols in comparison to
iohexol plasma clearances compared to inulin urinary
clearances. This once again is not unexpected, as the
physiological pattern of the marker can impact the
results. Also, we observed a significant bias between
urinary and plasma clearances of iohexol. This bias
has already been reported in previous studies, but
the underlying mechanisms remain not fully eluci-
dated.14,25 The current study, however, was not
designed to study the potential superiority of one
marker over another. The sample sizes of the marker
subgroups were too different to make any valuableKidney International Reports (2021) 6, 1622–1628
P Delanaye et al.: Plasma vs. Urinary Clearances in High GFR Ranges CLINICAL RESEARCHconclusion. Other studies comparing reference
markers with the same methodology (plasma or uri-
nary clearance) are still necessary to improve the
standardization of measured GFR.3,15,28,29 Accuracy
of all plasma clearances was also lower in the specific
group of patients with low BMI, which could be
explained by the fact that these equations were
developed in populations with standard weight and
height. In the same way, accuracy of all plasma
clearances were lower in hyperfiltrating subjects
(GFR > 130 ml/min per 1.73 m2). In this specific
group, the N and C equations could be slightly
better, even if their global performance remains
limited.11 The results in these 2 subgroups (low BMI
and GFR >130 ml/min per 1.73 m2) must be carefully
interpreted because of the limited sample (n¼31 and
32, respectively). Another limitation of the current
study is that the analysis is limited to adults.
In conclusion, among the equations used to correct
plasma clearances for the early compartment, the BM
and JBM equations are unbiased. In the very high GFR
range, results of these correction equations should be
interpreted with caution.APPENDIX
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